Breaking News
Get 60% Off 0
Black Friday Sale! Save huge on InvestingPro
Get up to 60% off
Close

Nippon India Pharma Fund - Direct Plan - Growth Plan (0P0000XVFK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
557.420 -3.340    -0.60%
27/11 - Closed. Currency in INR
Type:  Fund
Market:  India
ISIN:  INF204K01I50 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 86.89B
Reliance Pharma Fund - Direct Plan - Growth Plan 557.420 -3.340 -0.60%

0P0000XVFK Technical Analysis

 
A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Nippon India Pharma Fund - Direct Plan - Growth Plan fund. Access detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All 0P0000XVFK fund Technical Studies are available in different time frames.
Summary:Strong Sell
Moving Averages:SellBuy (5)Sell (7)
Technical Indicators:Strong SellBuy (3)Sell (6)

Pivot PointsNov 27, 2024 22:01 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 560.763 560.763 560.763 560.763 560.763 560.763 560.763
Fibonacci 560.763 560.763 560.763 560.763 560.763 560.763 560.763
Camarilla 560.763 560.763 560.763 560.763 560.763 560.763 560.763
Woodie's 560.763 560.763 560.763 560.763 560.763 560.763 560.763
DeMark's - - 560.764 560.764 560.764 - -

Technical IndicatorsNov 27, 2024 22:01 GMT

Name Value Action
RSI(14) 44.837 Sell
STOCH(9,6) 57.043 Buy
STOCHRSI(14) 61.008 Buy
MACD(12,26) -3.918 Sell
ADX(14) 100.000 Overbought
Williams %R -60.584 Sell
CCI(14) -32.2546 Neutral
ATR(14) 4.0940 Less Volatility
Highs/Lows(14) -2.3418 Sell
Ultimate Oscillator 52.007 Buy
ROC -1.691 Sell
Bull/Bear Power(13) -3.5582 Sell

Buy: 3

Sell: 6

Neutral: 1


Summary:Strong Sell

Moving AveragesNov 27, 2024 22:01 GMT

Period Simple Exponential
MA5 559.801
Sell
558.480
Sell
MA10 556.153
Buy
559.029
Sell
MA20 561.294
Sell
561.748
Sell
MA50 569.765
Sell
562.445
Sell
MA100 555.950
Buy
550.899
Buy
MA200 515.869
Buy
515.689
Buy

Buy: 5

Sell: 7


Summary:Sell

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XVFK Comments

Write your thoughts about Nippon India Pharma Fund - Direct Plan - Growth Plan
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email